Delhi Bans Sale of Coldrif Syrup After Deadly Contamination Reports
The Delhi government’s Drugs Control Department has issued a public interest notice banning the sale and consumption of Coldrif Syrup after laboratory tests found the medicine to be adulterated with Diethylene Glycol, a toxic chemical compound. The department confirmed that the syrup, manufactured by Seesan Pharmaceutical in Tamil Nadu, was declared “Not of Standard Quality” following an analysis by the Drugs Testing Laboratory in Madhya Pradesh.
The move comes after 20 children reportedly died in Madhya Pradesh due to suspected contamination linked to the same batch of Coldrif Syrup, prompting several states, including Kerala, Tamil Nadu, and Punjab, to impose similar bans. Madhya Pradesh Deputy Chief Minister and Health Minister Rajendra Shukla stated that four more children are currently under treatment. Authorities have advised all stakeholders to immediately cease the purchase, sale, and distribution of the product and have urged the public to avoid its use.
Meanwhile, the Drugs Controller General of India (DCGI), Dr. Rajeev Singh Raghuvanshi, has issued directives to all States and Union Territories to ensure strict adherence to the Drugs Rules, 1945. He emphasized the need for rigorous testing of raw materials and pharmaceutical formulations, including excipients, to prevent similar incidents in the future.
Pic Courtesy: google/ images are subject to copyright
